LON:SKIN - Integumen Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 2.21 -0.28 (-11.24 %) (As of 03/18/2019 04:00 PM ET)Previous CloseGBX 2.49Today's RangeGBX 2.16 - GBX 2.4652-Week RangeGBX 0.35 - GBX 2.58Volume13.19 million shsAverage Volume41,864 shsMarket Capitalization£10.49 millionP/E Ratio-0.50Dividend YieldN/ABetaN/A ProfileDiscussionChartHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Integumen Plc, a personal health care company, develops and commercializes a range of products for oral, skin, and wound care markets. The company develops TS1, a disposable tongue vacuum cleaner for professional use in the dental surgery, a tongue gel, and a handle, which turns the tongue vacuum cleaner into a tongue scraper for home use. It also offers Labskin, a 3-dimensional human skin equivalent model for basic and applied skin research, pre-clinical screening, microbial testing, and efficacy studies of personal care products. In addition, the company provides a range of cosmetic skincare products under the Stoer brand; consumer and professional cosmeceutical products under the Visible Youth brand for anti-ageing; and Clarogel, an over-the-counter cosmetic product for the treatment of blemishes. In addition, it offers Wound pHase, a diagnostic tool, which is used in the acidity/alkalinity of the wound; and hydrogel as a dressing for use in the treatment of burns. The company was incorporated in 2016 and is headquartered in Dalkey, Ireland. Receive SKIN News and Ratings via Email Sign-up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Household & Personal Products Sub-IndustryN/A SectorN/A Current SymbolLON:SKIN Previous Symbol CUSIPN/A CIKN/A Webwww.integumen.co.uk Phone+353-1-5373269Debt Debt-to-Equity RatioN/A Current Ratio0.11 Quick Ratio0.03Price-To-Earnings Trailing P/E Ratio-0.50 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£263,000.00 Price / Sales39.87 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX (0.40) per share Price / Book-5.53Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares474,451,008Market Cap£10.49 million Next Earnings DateN/A OptionableNot Optionable Integumen (LON:SKIN) Frequently Asked Questions What is Integumen's stock symbol? Integumen trades on the London Stock Exchange (LON) under the ticker symbol "SKIN." Has Integumen been receiving favorable news coverage? Media coverage about SKIN stock has trended somewhat positive recently, InfoTrie reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Integumen earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days. Who are some of Integumen's key competitors? Some companies that are related to Integumen include BOD Australia (BDA), Orchids Paper Products (TIS), Beiersdorf (BDRFF), Biologix Hair (BLGX), Dogness International (DOGZ), ESSITY AKTIEBOL/S (ESSYY), Henkel AG & Co KGaA (HEN3), HENKEL AG & CO/S (HENOY), Joey New York (JOEY), Kimberly Parry Organics (KPOC), L'Oreal (OR) and Radiant Creations Group (RCGP). What other stocks do shareholders of Integumen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Integumen investors own include Learning Technologies Group (LTG). Who are Integumen's key executives? Integumen's management team includes the folowing people: Mr. Christopher Bell, CFO, Company Sec. & Exec. DirectorMr. Donald Nicholson, Exec. Director (Age 61)Mr. Gerard James Brandon, CEO & Director (Age 57)Mr. Camillus Gerard Glover, COO & Director (Age 58)Alex Chapman, Head of Labskin Operations How do I buy shares of Integumen? Shares of SKIN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Integumen's stock price today? One share of SKIN stock can currently be purchased for approximately GBX 2.21. How big of a company is Integumen? Integumen has a market capitalization of £10.49 million and generates £263,000.00 in revenue each year. What is Integumen's official website? The official website for Integumen is http://www.integumen.co.uk/. How can I contact Integumen? Integumen's mailing address is Dalkey, 19 Railway Road, DUBLIN, YO41 1LZ, Ireland. The company can be reached via phone at +353-1-5373269. MarketBeat Community Rating for Integumen (LON SKIN)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 18 (Vote Outperform)Underperform Votes: 20 (Vote Underperform)Total Votes: 38MarketBeat's community ratings are surveys of what our community members think about Integumen and other stocks. Vote "Outperform" if you believe SKIN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SKIN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/18/2019 by MarketBeat.com StaffFeatured Article: What are the reasons investors use put options?